Clinical Central Laboratory Services

The Clinical Central Laboratory Services Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), supports extramural research focused on infectious, immunologic, and allergic diseases. The contract provides comprehensive central laboratory services to support scientific research, specifically targeting the development and evaluation of therapeutics, vaccines, and diagnostics. Task orders under this vehicle are designed to facilitate clinical and applied research across various disease study protocols, with a primary emphasis on supporting medical research initiatives.

Task orders under this IDIQ have consistently been awarded to PPD Global Central Labs LLC, with values ranging from approximately $41,000 to $1,063,455 and typical performance periods between 12-24 months. The delivery orders consistently involve clinical central laboratory services, often supporting specific research protocols such as Vaccine and Treatment Evaluation Units (VTEU) and studies related to influenza and biodefense. All task orders have been awarded on a firm fixed-price basis with no specific small business set-aside designations. Performance locations appear to include Kentucky, with work primarily conducted for civilian agencies within the Department of Health and Human Services. The task orders demonstrate a consistent pattern of supporting medical research through laboratory services, with a focus on infectious disease studies and clinical protocol support.